Columbia, MO, United States of America

Dhananjay Suresh

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2019-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dhananjay Suresh: Innovator in Cancer Treatment

Introduction

Dhananjay Suresh is a prominent inventor based in Columbia, MO (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. With a total of 2 patents, Suresh is dedicated to developing methods that enhance the effectiveness of cancer therapies.

Latest Patents

Suresh's latest patents include groundbreaking work on compositions for the treatment of drug-resistant tumors. These patents provide methods and compositions for sensitizing cancer cells to treatments, such as anticancer drugs, by inhibiting at least two cancer biomarkers. Additionally, he has developed methods for treating and preventing cancer, which include reducing tumor size. Another notable patent involves targeted nanoparticle conjugates for the co-delivery of siRNA and drugs. This innovation features nanoparticle conjugates that encapsulate drugs in gelatin nanoparticles, functionalized with antibodies linked to siRNA, offering new methods for treating diseases.

Career Highlights

Dhananjay Suresh is affiliated with the University of Missouri, where he conducts his research and development work. His focus on cancer treatment has positioned him as a key figure in the academic and scientific community.

Collaborations

Suresh collaborates with esteemed colleagues, including Raghuraman Kannan and Anandhi Upendran, to further advance his research initiatives.

Conclusion

Dhananjay Suresh's innovative work in cancer treatment exemplifies the impact of research and invention in addressing critical health challenges. His contributions through patents and collaborations continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…